Feb 06, 2018
BD Announces Results For 2018 First Fiscal Quarter; Provides Fiscal 2018 Guidance Updated For Inclusion Of Bard
Jan 22, 2018
BD Board Declares Dividend
Jan 17, 2018
BD Announces Webcast of Annual Meeting of Shareholders
Jan 12, 2018
BD Statement on FDA Warning Letter for Preanalytical Systems Business Unit
Jan 11, 2018
BD Announces Live Webcast Of First Fiscal Quarter Earnings Conference Call
Jan 03, 2018
BD to Present at the 36th Annual J. P. Morgan Healthcare Conference
Dec 29, 2017
BD Completes Bard Acquisition, Creating New Global Health Care Leader
Dec 28, 2017
BD Statement On MOFCOM Clearance Of Bard Acquisition
Dec 22, 2017
BD Statement On FTC Clearance Of Bard Acquisition
Dec 11, 2017
BD Establishes Product Security Partnership Program to Enhance Cybersecurity of Medical Technology
Dec 04, 2017
BD Announces New Offerings to Help Customers Deliver Safer, Simpler and Smarter Medication Management
Nov 20, 2017
BD Board Increases Dividend
Nov 16, 2017
BD to Introduce Integrated Medication Management Platform Designed to Address Hospitals' Greatest Challenges at #ASHP17
Nov 16, 2017
BD Statement On Merit Medical Agreement To Purchase BD, Bard Product Lines
Nov 02, 2017
BD Announces Results For 2017 Fourth Fiscal Quarter And Full Year; Provides Fiscal 2018 Guidance
Oct 25, 2017
BD Breaks Ground on $60 Million Expansion of Nebraska Manufacturing Facility
Oct 18, 2017
BD Statement On European Commission Conditional Clearance Of Bard Acquisition
Oct 05, 2017
BD Announces Live Webcast of Fourth Fiscal Quarter Earnings Conference Call
Sep 29, 2017
Timothy M. Ring and David F. Melcher to Join BD Board of Directors
Sep 12, 2017
BD Expands Genomics Portfolio with New Single Cell Platform for RNA Expression Analysis